Please assess the completion status of the following clinical trial:

Trial Title: CoQ10 and Prednisone in Non-Ambulatory DMD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Age 10-18 years~* Non-ambulatory (primary mode of transportation is via wheelchair for 3 years or less)~* Confirmed DMD diagnosis~* Steroid-naive for the 6 months prior to screening~* Stable dose of b-blocker or ACE inhibitor medication for the 6 months prior to screening, if taking either of these medications~* Ability to provide reproducible repeat QMT grip score within 15% of first assessment score~* Has not participated in other therapeutic research protocol within the last 6 months prior to screening~* Ability to swallow tablets~Exclusion Criteria:~* Failure to achieve one or more of the diagnostic inclusion criteria cited above~* Symptomatic DMD carrier~* Use of carnitine, other amino acids, creatine, glutamine, CoQ10 or any herbal medicines (this would not include herbal teas unless they are consumed daily with intended medicinal effect) within the last 3 months~* History of significant concomitant illness or significant impairment of renal or hepatic function, or other contraindication to steroid therapy~* Positive PPD~* No prior exposure to chickenpox and no immunization against chicken pox~* Baseline serum CoQ10 level of 5.0mg/ml or greater

- Gender: MALE
- Minimum Age: 10 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): CoenzymeQ10 taken once a day each morning by mouth.
- 2 (Type: ACTIVE_COMPARATOR): Prednisone taken once a day each morning by mouth
- 3 (Type: ACTIVE_COMPARATOR): CoenzymeQ10 and prednisone each taken once a day in the morning by mouth.
- 4 (Type: NO_INTERVENTION): Enhanced standard of care.

Based on this trial design, predict the completion outcome and termination type (if applicable).